Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000463659 | SCV000557267 | benign | Hereditary spastic paraplegia 11 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721515 | SCV000569378 | benign | not provided | 2019-03-28 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848825 | SCV002105689 | likely benign | Hereditary spastic paraplegia | 2021-04-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002467826 | SCV002764032 | likely benign | Amyotrophic lateral sclerosis type 5 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467827 | SCV002764033 | likely benign | Charcot-Marie-Tooth disease axonal type 2X | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV000463659 | SCV002764034 | likely benign | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing | ||
Ce |
RCV001721515 | SCV004698415 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SPG11: BP4, BS1, BS2 |
Prevention |
RCV003899960 | SCV004719835 | benign | SPG11-related disorder | 2024-01-18 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |